Developer docs
API playgroundTry for free, no card

Search company profiles

1mg Labs

Full company profile

uuid00szfcl

Namestring
1mg Labs
Legal namestring
Tata 1mg (1mg Labs)
Websiteurl
1mglabs.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Tata 1mg (1mg Labs) is India's largest integrated digital healthcare platform, founded in 2015 and acquired by Tata Group in 2021 as part of Tata Digital. The platform combines an e-pharmacy ranked #1 in India, diagnostic lab booking across a partner network of 120+ ISO/NABL/CAP accredited labs and 19 owned NABL-accredited labs spanning 55+ cities, online doctor consultations covering 20+ specialties, specialty pharma distribution, and an expanding offline retail footprint of 280+ stores (targeting 500+). Home sample collection with live phlebotomist tracking, doctor-verified digital reports delivered via email and WhatsApp, and a subscription Care Plan form the core service experience.

The underlying technology stack centers on a consumer-facing mobile app and website integrated with logistics and lab-network APIs; AI features for prescription interpretation, medical report analysis, and personalized recommendations are used by over 30% of customers. Tata 1mg also embeds its services into third-party platforms via integrations such as Samsung Health's Find Care feature and OneBanc's AI-driven corporate payroll systems, plus partnerships with Anytime Fitness India for preventive diagnostics and Vedanta Aluminium for rural telemedicine.

Revenue is generated primarily through transaction fees on e-pharmacy, diagnostics, doctor consultations, and specialty pharma orders, with a subscription Care Plan for consumers and a recurring corporate wellness model for B2B clients. The company reported approximately Rs 1,900+ crore in FY24/25 revenue, achieved EBITDA positivity across all core businesses in FY26, and received a $300M capital allocation from Tata Group's broader $1.3B Tata Digital fundraise to fund expansion.

Short descriptiontext

1mg Labs (Tata 1mg) is India's largest integrated digital healthcare platform, offering e-pharmacy, diagnostics booking across 120+ accredited labs, telemedicine, specialty pharma, and offline retail, serving individual consumers and corporate clients across 55+ cities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersNew Delhi, India
HQ citystring
New Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
online pharmacy services, diagnostic lab tests, telemedicine consultations, digital healthcare platform, medicine delivery service
Industry2 codes
1Clinical Laboratory LIS (Core Lab/Hospital Lab)
CodeHLACAMAAPrimaryYes
2Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
CodeHLAGAEABPrimaryNo
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Digital Healthcare Platform
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model6 records
1E-Pharmacy
TypeTransaction Fee
Description

Online medicine sales through 1mg platform, ranked #1 in India. The ePharmacy business achieved breakeven in FY26.

digitalhealthnews.com
2Diagnostics
TypeTransaction Fee
Description

Lab test booking services through partner network of NABL-accredited labs. Diagnostics business crossed annualized revenue run rate of over Rs 600 crore with over 40% year-on-year growth and double-digit EBITDA margins.

thehindubusinessline.com
3Specialty Pharma
TypeTransaction Fee
Description

Specialty pharmaceutical distribution business growing approximately 65% year-over-year.

thehindubusinessline.com
4Doctor Consultations
TypeTransaction Fee
Description

Online doctor consultation services through platform with access to over 20 specialist types.

fortuneindia.com
5Direct-to-Consumer Health Products
TypeTransaction Fee
Description

D2C health and wellness products business crossing Rs 200 crore in annual recurring revenue.

fortuneindia.com
6Corporate Wellness
TypeSubscription Recurring
Description

B2B corporate healthcare services integrated into payroll systems through partnerships, targeting India's corporate health market exceeding Rs 12,000 crore annually.

bwhealthcareworld.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
Pricing details2 tiers
1Lab tests available at discounted prices with options to compare tests and packages based on prices and lab ratings
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Consumers can choose diagnostic lab of preference and book tests at discounted prices while maintaining quality of service.

2Corporate wellness plan integrated into payroll with AI-driven health hub
ModelSubscriptionBilling cadenceMonthly
Notes

Partnership with OneBanc embeds healthcare services into corporate payroll systems targeting India's corporate wellness market valued at Rs 21,000 crore and growing at 5% CAGR.

bwhealthcareworld.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

1mg Labs (Tata 1mg) operates an integrated digital healthcare platform enabling consumers to book diagnostic lab tests and radiology scans with home sample collection by trained phlebotomists, receive doctor-verified digital reports via email and WhatsApp, and access online doctor consultations across 20+ specialties. The platform also sells medicines and health products online, complemented by an offline retail footprint of 280+ stores across India and a network of 120+ NABL/CAP-certified partner labs in 55+ cities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • EBITDA positive across all established businesses in FY26
+4 more records
Product overview1 text field

Tata 1mg is India's largest integrated digital healthcare platform operating as a multi-module ecosystem comprising online pharmacy (ranked #1 in India), diagnostic lab services (Tata 1mg Labs with 120+ certified partner labs offering 2,000+ tests), online doctor consultations (20+ specialties), cancer care, ayurveda, and specialty pharma. The platform combines these services with a subscription Care Plan, corporate wellness partnerships, and an expanding offline retail footprint of 280+ stores for omnichannel delivery. The platform serves over 55 cities with AI-powered features for medical report analysis and personalized care used by over 30% of customers.

Product and service9 records
1Tata 1mg Online Pharmacy
CategoryOnline Pharmacy
Description

E-pharmacy platform ranked #1 in India enabling online ordering of medicines with home delivery services.

2Tata 1mg Labs (Diagnostic Lab Tests)
CategoryDiagnostic Services
Description

Diagnostic lab testing service offering over 2,000 tests from 120+ NABL/CAP-certified partner labs with home sample collection, live phlebotomist tracking, and doctor-verified digital reports. Service covers 55+ cities with over 4,500,000 lab tests booked.

3Online Doctor Consultation
CategoryTelemedicine
Description

Telemedicine platform providing access to 20+ specialist and super-specialist doctors for online consultations via audio and video, including result verification services.

4Cancer Care
CategorySpecialty Healthcare
Description

Comprehensive cancer care information and medication platform providing resources and support for cancer patients.

5Ayurveda
CategoryAlternative Medicine
Description

Ayurvedic medicines and wellness products category offering traditional herbal healthcare solutions.

6Care Plan (Subscription)
CategorySubscription Service
Description

Subscription plan offering exclusive benefits including free diabetes test packages and priority access to diagnostics and medicines.

7Corporate Wellness
CategoryCorporate Wellness
Description

B2B healthcare services for corporate clients providing employee health benefits, diagnostics, and preventive wellness programs.

8Specialty Pharma
CategoryPharmaceutical Distribution
Description

Specialty pharmaceutical distribution business serving specialized medications beyond standard e-pharmacy offerings, growing approximately 65% year-over-year.

9Radiology Services
CategoryDiagnostic Imaging
Description

Radiology diagnostic services including CT scans, MRI, X-rays, ultrasound, ECG, and echocardiography tests booked through the platform.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-08
Description

Vedanta Aluminium launched a 24x7 telemedicine facility in Lanjigarh, Kalahandi district, Odisha, in partnership with Tata 1mg. The service provides free audio and video consultations with nearly 30 specialist and super-specialist doctors, expected to benefit over 70,000 people across approximately 70 remote villages, reducing long-distance travel for medical guidance.

2Samsung Health
Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2026-02-24
Description

Samsung Health introduced Find Care feature in India through partnerships with Tata 1mg and PharmEasy. The feature enables users to order medications, book diagnostic tests, and consult doctors online directly through the Samsung Health app, eliminating the need to switch between platforms.

sammyguru.com
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2026-02-03
Description

Anytime Fitness India entered a pan-India partnership with Tata 1mg to integrate preventive healthcare diagnostics into its fitness ecosystem. Anytime Fitness members access diagnostic testing services including metabolic, cardiac, kidney, and blood marker tracking through exclusive health packages, combining gym network with Tata 1mg's diagnostics and pharmacy services.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-04
Description

Tata 1mg and OneBanc partnered to embed healthcare services directly into OneBanc's AI-driven salary infrastructure, creating a personalized health hub within corporate payroll systems. OneBanc's AI SmartRoute technology predicts employee healthcare needs and triggers timely nudges, leveraging Tata 1mg's medicines inventory, NABL-accredited diagnostics, and delivery network.

Strategic tierCoreTypeTechnology or Integration
Description

Tata 1mg partners with various recognized diagnostic labs certified by international bodies including ISO (International Organization for Standardization), NABL (National Accreditation Board for testing and calibration laboratories), and CAP (College of American Pathologists) to ensure quality in sample collection, hygiene standards, and high accuracy in results.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Established pan-India diagnostics chain with a strong B2B and B2C presence. Represents the offline incumbent that Tata 1mg's diagnostics platform competes against for lab test volumes.

TypeDirect peer
Description

Reliance-owned e-pharmacy and diagnostics platform competing in online medicine delivery and lab test bookings. Has similar omnichannel ambitions and access to deep capital from its parent.

TypeDirect peer
Description

Apollo Hospitals' digital platform offering online pharmacy, diagnostic bookings, and teleconsultations. Directly comparable to Tata 1mg's integrated healthcare stack and backed by Apollo's hospital network.

TypeEmerging player
Description

AI-driven telemedicine and online consultation platform in India. Comparable to Tata 1mg's telemedicine vertical and overlaps on AI-assisted health consultations.

TypeBroad incumbent
Description

Large reference lab network and diagnostics service provider in India. Competes with Tata 1mg's diagnostics vertical, particularly in routine and specialty lab testing for hospitals and consumers.

TypeEmerging player
Description

Digital health platform specializing in corporate wellness, teleconsultations, and diagnostics. Comparable to Tata 1mg's corporate wellness and telemedicine offerings.

TypeDirect peer
Description

Direct competitor in Indian e-pharmacy and home diagnostics booking. Competes head-to-head with Tata 1mg on online medicine delivery and at-home lab test bookings, including the Samsung Health 'Find Care' integration.

TypeDirect peer
Description

Pan-India diagnostic chain acquired by PharmEasy. Operates a centralized diagnostic lab model that competes with Tata 1mg's diagnostics platform in affordable preventive health packages.

TypeEmerging player
Description

Home diagnostics specialist focused on at-home sample collection and online lab bookings. Directly comparable to Tata 1mg's diagnostics vertical with similar home-collection operating model.

TypeDirect peer
Description

India's leading doctor consultation and diagnostics booking platform. Overlaps with Tata 1mg on online consultations and lab test bookings, and competes for the same consumer mindshare in digital health.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

1mg Labs

Digital Healthcare Platform1mglabs.com

1mg Labs (Tata 1mg) is India's largest integrated digital healthcare platform, offering e-pharmacy, diagnostics booking across 120+ accredited labs, telemedicine, specialty pharma, and offline retail, serving individual consumers and corporate clients across 55+ cities.

What 1mg Labs does

Tata 1mg (1mg Labs) is India's largest integrated digital healthcare platform, founded in 2015 and acquired by Tata Group in 2021 as part of Tata Digital. The platform combines an e-pharmacy ranked #1 in India, diagnostic lab booking across a partner network of 120+ ISO/NABL/CAP accredited labs and 19 owned NABL-accredited labs spanning 55+ cities, online doctor consultations covering 20+ specialties, specialty pharma distribution, and an expanding offline retail footprint of 280+ stores (targeting 500+). Home sample collection with live phlebotomist tracking, doctor-verified digital reports delivered via email and WhatsApp, and a subscription Care Plan form the core service experience.

The underlying technology stack centers on a consumer-facing mobile app and website integrated with logistics and lab-network APIs; AI features for prescription interpretation, medical report analysis, and personalized recommendations are used by over 30% of customers. Tata 1mg also embeds its services into third-party platforms via integrations such as Samsung Health's Find Care feature and OneBanc's AI-driven corporate payroll systems, plus partnerships with Anytime Fitness India for preventive diagnostics and Vedanta Aluminium for rural telemedicine.

Revenue is generated primarily through transaction fees on e-pharmacy, diagnostics, doctor consultations, and specialty pharma orders, with a subscription Care Plan for consumers and a recurring corporate wellness model for B2B clients. The company reported approximately Rs 1,900+ crore in FY24/25 revenue, achieved EBITDA positivity across all core businesses in FY26, and received a $300M capital allocation from Tata Group's broader $1.3B Tata Digital fundraise to fund expansion.

1mg Labs firmographics

Firmographics
Name
1mg Labs
Legal name
Tata 1mg (1mg Labs)
Website
https://1mglabs.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
251–500 employees
Short description
1mg Labs (Tata 1mg) is India's largest integrated digital healthcare platform, offering e-pharmacy, diagnostics booking across 120+ accredited labs, telemedicine, specialty pharma, and offline retail, serving individual consumers and corporate clients across 55+ cities.
Ownership category
akta.pro rank

1mg Labs industry classification

Industry
Product category
Digital Healthcare Platform
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Clinical Laboratory LIS (Core Lab/Hospital Lab) (HLACAMAA)
akta.pro secondary industry
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

  • Online pharmacy services
  • Diagnostic lab tests
  • Telemedicine consultations
  • Digital healthcare platform
  • Medicine delivery service

Where 1mg Labs is headquartered

Location

Headquarters

HQ city
New Delhi
HQ country
India
HQ region
Asia

Offices1 record

Markets served

1mg Labs business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. E-Pharmacy: Online medicine sales through 1mg platform, ranked #1 in India. The ePharmacy business achieved breakeven in FY26.
  2. Diagnostics: Lab test booking services through partner network of NABL-accredited labs. Diagnostics business crossed annualized revenue run rate of over Rs 600 crore with over 40% year-on-year growth and double-digit EBITDA margins.
  3. Specialty Pharma: Specialty pharmaceutical distribution business growing approximately 65% year-over-year.
  4. Doctor Consultations: Online doctor consultation services through platform with access to over 20 specialist types.
  5. Direct-to-Consumer Health Products: D2C health and wellness products business crossing Rs 200 crore in annual recurring revenue.
  6. Corporate Wellness: B2B corporate healthcare services integrated into payroll systems through partnerships, targeting India's corporate health market exceeding Rs 12,000 crore annually.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goLab tests available at discounted prices with options to compare tests and packages based on prices and lab ratings
SubscriptionMonthlyCorporate wellness plan integrated into payroll with AI-driven health hub

Go-to-market motion3 records

Distribution channels5 records

Marketing channels4 records

1mg Labs product offering

Product offering

Core offering

1mg Labs (Tata 1mg) operates an integrated digital healthcare platform enabling consumers to book diagnostic lab tests and radiology scans with home sample collection by trained phlebotomists, receive doctor-verified digital reports via email and WhatsApp, and access online doctor consultations across 20+ specialties. The platform also sells medicines and health products online, complemented by an offline retail footprint of 280+ stores across India and a network of 120+ NABL/CAP-certified partner labs in 55+ cities.

Product overview

Tata 1mg is India's largest integrated digital healthcare platform operating as a multi-module ecosystem comprising online pharmacy (ranked #1 in India), diagnostic lab services (Tata 1mg Labs with 120+ certified partner labs offering 2,000+ tests), online doctor consultations (20+ specialties), cancer care, ayurveda, and specialty pharma. The platform combines these services with a subscription Care Plan, corporate wellness partnerships, and an expanding offline retail footprint of 280+ stores for omnichannel delivery. The platform serves over 55 cities with AI-powered features for medical report analysis and personalized care used by over 30% of customers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Tata 1mg Online Pharmacy E-pharmacy platform ranked #1 in India enabling online ordering of medicines with home delivery services.
  • Tata 1mg Labs (Diagnostic Lab Tests) Diagnostic lab testing service offering over 2,000 tests from 120+ NABL/CAP-certified partner labs with home sample collection, live phlebotomist tracking, and doctor-verified digital reports. Service covers 55+ cities with over 4,500,000 lab tests booked.
  • Online Doctor Consultation Telemedicine platform providing access to 20+ specialist and super-specialist doctors for online consultations via audio and video, including result verification services.
  • Cancer Care Comprehensive cancer care information and medication platform providing resources and support for cancer patients.
  • Ayurveda Ayurvedic medicines and wellness products category offering traditional herbal healthcare solutions.
  • Care Plan (Subscription) Subscription plan offering exclusive benefits including free diabetes test packages and priority access to diagnostics and medicines.
  • Corporate Wellness B2B healthcare services for corporate clients providing employee health benefits, diagnostics, and preventive wellness programs.
  • Specialty Pharma Specialty pharmaceutical distribution business serving specialized medications beyond standard e-pharmacy offerings, growing approximately 65% year-over-year.
  • Radiology Services Radiology diagnostic services including CT scans, MRI, X-rays, ultrasound, ECG, and echocardiography tests booked through the platform.

Quantifiable outcome

  • EBITDA positive across all established businesses in FY26
  • +4 more outcomes

Companies that use 1mg Labs

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

1mg Labs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature4 records

1mg Labs partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and flagship.

  • Vedanta AluminiumcoreStrategic or Co-development Partner · 8 May 2026Vedanta Aluminium launched a 24x7 telemedicine facility in Lanjigarh, Kalahandi district, Odisha, in partnership with Tata 1mg. The service provides free audio and video consultations with nearly 30 specialist and super-specialist doctors, expected to benefit over 70,000 people across approximately 70 remote villages, reducing long-distance travel for medical guidance.
  • Samsung HealthflagshipGTM or Marketing Partner · 24 February 2026Samsung Health introduced Find Care feature in India through partnerships with Tata 1mg and PharmEasy. The feature enables users to order medications, book diagnostic tests, and consult doctors online directly through the Samsung Health app, eliminating the need to switch between platforms.
  • Anytime Fitness IndiacoreGTM or Marketing Partner · 3 February 2026Anytime Fitness India entered a pan-India partnership with Tata 1mg to integrate preventive healthcare diagnostics into its fitness ecosystem. Anytime Fitness members access diagnostic testing services including metabolic, cardiac, kidney, and blood marker tracking through exclusive health packages, combining gym network with Tata 1mg's diagnostics and pharmacy services.
  • OneBanccoreStrategic or Co-development Partner · 4 January 2026Tata 1mg and OneBanc partnered to embed healthcare services directly into OneBanc's AI-driven salary infrastructure, creating a personalized health hub within corporate payroll systems. OneBanc's AI SmartRoute technology predicts employee healthcare needs and triggers timely nudges, leveraging Tata 1mg's medicines inventory, NABL-accredited diagnostics, and delivery network.
  • Diagnostic Lab Partners (ISO/NABL/CAP Certified)coreTechnology or IntegrationTata 1mg partners with various recognized diagnostic labs certified by international bodies including ISO (International Organization for Standardization), NABL (National Accreditation Board for testing and calibration laboratories), and CAP (College of American Pathologists) to ensure quality in sample collection, hygiene standards, and high accuracy in results.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

1mg Labs competitors and assessment

Company assessment

Broad incumbents

  • Metropolis Healthcare: Established pan-India diagnostics chain with a strong B2B and B2C presence. Represents the offline incumbent that Tata 1mg's diagnostics platform competes against for lab test volumes.
  • SRL Diagnostics: Large reference lab network and diagnostics service provider in India. Competes with Tata 1mg's diagnostics vertical, particularly in routine and specialty lab testing for hospitals and consumers.

Direct peers

  • Netmeds (Reliance): Reliance-owned e-pharmacy and diagnostics platform competing in online medicine delivery and lab test bookings. Has similar omnichannel ambitions and access to deep capital from its parent.
  • Apollo 24/7: Apollo Hospitals' digital platform offering online pharmacy, diagnostic bookings, and teleconsultations. Directly comparable to Tata 1mg's integrated healthcare stack and backed by Apollo's hospital network.
  • PharmEasy: Direct competitor in Indian e-pharmacy and home diagnostics booking. Competes head-to-head with Tata 1mg on online medicine delivery and at-home lab test bookings, including the Samsung Health 'Find Care' integration.
  • Thyrocare Technologies: Pan-India diagnostic chain acquired by PharmEasy. Operates a centralized diagnostic lab model that competes with Tata 1mg's diagnostics platform in affordable preventive health packages.
  • Practo: India's leading doctor consultation and diagnostics booking platform. Overlaps with Tata 1mg on online consultations and lab test bookings, and competes for the same consumer mindshare in digital health.

Emerging players

  • MFine: AI-driven telemedicine and online consultation platform in India. Comparable to Tata 1mg's telemedicine vertical and overlaps on AI-assisted health consultations.
  • MediBuddy: Digital health platform specializing in corporate wellness, teleconsultations, and diagnostics. Comparable to Tata 1mg's corporate wellness and telemedicine offerings.
  • Healthians: Home diagnostics specialist focused on at-home sample collection and online lab bookings. Directly comparable to Tata 1mg's diagnostics vertical with similar home-collection operating model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

1mg Labs social profiles

Digital presence

1mg Labs compliance and trust

Trust signal

Compliance3 records

1mg Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

1mg Labs leadership team

Management profile

Number of profiles

1mg Labs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

1mg Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 1mg Labs

What does 1mg Labs do?

1mg Labs (Tata 1mg) operates an integrated digital healthcare platform enabling consumers to book diagnostic lab tests and radiology scans with home sample collection by trained phlebotomists, receive doctor-verified digital reports via email and WhatsApp, and access online doctor consultations across 20+ specialties. The platform also sells medicines and health products online, complemented by an offline retail footprint of 280+ stores across India and a network of 120+ NABL/CAP-certified partner labs in 55+ cities.

Is 1mg Labs a public or private company?

1mg Labs is a private company. It is classified as corporate owned and is currently operating.

When was 1mg Labs founded?

1mg Labs was founded in 2015. It employs 251 to 500 people.

Where is 1mg Labs based?

1mg Labs is headquartered in New Delhi, India, in the Asia region.

How does 1mg Labs make money?

Six revenue lines are on record. E-Pharmacy is the primary driver. The others are diagnostics, specialty Pharma, doctor Consultations, direct-to-Consumer Health Products and corporate Wellness.

Who are 1mg Labs's main competitors?

Broad incumbents on record are Metropolis Healthcare and SRL Diagnostics. Direct peers are Netmeds (Reliance), Apollo 24/7, PharmEasy, Thyrocare Technologies and Practo. Emerging players are MFine, MediBuddy and Healthians.

Does 1mg Labs have an API?

No public API is recorded for 1mg Labs.

What industry is 1mg Labs in?

1mg Labs's product category is Digital Healthcare Platform. Its primary akta.pro industry code is HLACAMAA, Clinical Laboratory LIS (Core Lab/Hospital Lab), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The KenTata 1mg refused to get carried away in the e-pharmacy battle. It’s in no mood to change its mindTata 1mg, acquired by Tata Digital in 2021 for a 55% stake when revenue stood at Rs 309 crore, has grown its revenue tenfold to nearly Rs 3,000 crore in FY26 and become net-profitable, with its diagnostics vertical alone crossing Rs 600 crore in annualized revenue. Unlike competitors Pharmeasy and Netmeds, which pursued aggressive discounting and debt-fuelled acquisitions leading to Pharmeasy's valuation declining from $5.6 billion in 2021 to $710 million in 2024, Tata 1mg resisted these trends and focused on being a healthcare company rather than just an e-pharmacy.EntrackrTata 1mg revenue nears Rs 3,000 Cr in FY26; loss narrows to Rs 287 CrTata 1mg's consolidated revenue grew 23% to Rs 2,936 crore in FY26, while its net loss narrowed to Rs 287 crore. The loss came from Tata 1mg Healthcare Solutions, which posted a Rs 310 crore loss, offset by a Rs 23 crore profit from Tata 1mg Technologies.InstagramInstagramIndia's ₹4 lakh crore pharmacy market is experiencing a significant shift as online pharmacies like Tata 1mg and PharmEasy compete with traditional local chemists. The competition revolves around consumer trust and convenience, with no clear winner yet.Business TodayThe obesity market will only get tougher from here, says Novo EVPNovo Nordisk launched Ozempic in India and reduced the price of Wegovy by 37% to expand its market presence amid intensifying competition for GLP-1 obesity treatments. The company is pursuing a dual strategy of direct sales and partnerships with local entities like Mcure and digital platforms such as Tata 1mg to improve patient access and affordability. This move aims to secure Novo Nordisk's position against competitors like Eli Lilly while leveraging its extensive clinical data, including trials conducted in India.The Times of IndiaMoUs signed to ensure health and wellness of police families in stateWAMA Saarthi, the UP Police Family Welfare Association, signed Memorandums of Understanding with Tata 1mg and Apollo Hospital to enhance healthcare access for police families in Uttar Pradesh. The agreement includes diagnostic camps by Tata 1mg in nine districts and health cards from Apollo Hospital for women over 40, alongside monthly homoeopathy wellness camps led by the AYUSH department across all districts.MintDiagnostic chains weigh in as weight-loss drugs take off in India | MintIndian diagnostic chains are launching specialized monitoring packages for patients on GLP-1 weight-loss drugs, with Tata 1mg's 'Weightwise' programme recording 2,000 sign-ups and Thyrocare Technologies launching an 81-test 'GLP-1 Health Check' package priced at ₹2,799. Eli Lilly's Mounjaro became India's top-selling brand in October 2025 with monthly sales of ₹100 crore, while Novo Nordisk launched Wegovy in July 2025, as both companies compete in the nascent Indian market expected to reach 5 million GLP-1 patients within five years. However, analysts caution that the diagnostic opportunity may not scale proportionally to the pharmaceutical boom, as many tests involved are routine or prescribed only pre- and post-therapy.The Indian ExpressHealth-tech company Ultrahuman partners with Tata 1mg, ‘Blood Vision’ service now available in over 60 cities across the countryHealth-tech company Ultrahuman has partnered with Tata 1mg to make its 'Blood Vision' service available in over 60 cities across India. The service allows users to receive health findings directly on the Ultrahuman app, bypassing traditional complicated PDF reports.KloudfuseKloudfuse Announces Observability Transformation at Tata 1mgKloudfuse announced a partnership with Tata 1mg to implement its AI-powered unified observability platform, resulting in a 40% reduction in operational costs for the digital healthcare provider. The integration enabled over 300 engineers at Tata 1mg to consolidate fragmented monitoring tools, significantly improving system performance and troubleshooting capabilities across their microservices architecture. This transition replaced legacy open-source solutions with a centralized platform designed to enhance visibility into Kubernetes events and overall system health.The Times of IndiaLosses@₹17k crore, Tata Group keeps faith in e‑comm with fresh ₹4k crore bet - The Economic TimesTata Group invested ₹4,000 crore of fresh equity into its e-commerce arm Tata Digital in FY25, despite accumulated losses of ₹16,958.3 crore as of March 2025, with all primary businesses including Croma, Big Basket, Tata 1MG, and Tata Cliq remaining loss-making. The company incurred losses of ₹4,609.9 crore last fiscal year, up 9.5% year-on-year, while finance costs surged 41% to ₹1,500 crore and total borrowings reached ₹9,000 crore. Management assessed going concern assumptions due to accumulated losses and net current liability of ₹4,413.9 crore but cited positive net worth of ₹8,189.4 crore and past fundraising ability as basis for believing the business remains viable.TracxnTop Companies in Online Pharmacy (Oct, 2025)The article presents a ranking of top online pharmacy startups as of October 2025, highlighting Tata 1mg, SastaSundar, Alto, and PillPack based on their market presence and funding. It details key metrics for each company, including founding years, locations, total funding amounts, and investor information. The text also notes that several of these startups were founded by alumni from prestigious universities like Harvard and Stanford.